2021
DOI: 10.1016/bs.pmbts.2021.01.003
|View full text |Cite
|
Sign up to set email alerts
|

Development of insect cell line using CRISPR technology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 65 publications
0
3
0
Order By: Relevance
“…In this cell line, the inactivation of CDKN2A at two loci induced immortalization, but also maintained the characteristics of normal cells, including a normal p53 response [ 56 ] . CRISPR-Cas9 has also been used to edit several existing insect cell lines, including insect cell lines Sf-21 and S2R+ [ 78 , 79 ] . Despite great potential, CRISPR-Cas9 has not yet been employed to produce a novel insect cell line.…”
Section: Producing Immortalized Insect Gut Cell Linesmentioning
confidence: 99%
“…In this cell line, the inactivation of CDKN2A at two loci induced immortalization, but also maintained the characteristics of normal cells, including a normal p53 response [ 56 ] . CRISPR-Cas9 has also been used to edit several existing insect cell lines, including insect cell lines Sf-21 and S2R+ [ 78 , 79 ] . Despite great potential, CRISPR-Cas9 has not yet been employed to produce a novel insect cell line.…”
Section: Producing Immortalized Insect Gut Cell Linesmentioning
confidence: 99%
“…Of note, a technique for CRISPR/Cas9 gene editing in Sf9 insect cells was first performed by Donald L. Jarvis and colleagues [ 126 ]. The team used the CRISPR-Cas9 vector as a platform to produce recombinant glycoproteins [ 127 ]. They also evaluated the potential for site-specific gene editing in baculovirus insect cell system (BICS) host insect cell lines by using several types of insect cell U6 promoters upstream of gene cassette to create CRISPR-Cas9 expression vector in Sf9 and High Five cells.…”
Section: The Future Of Crispr/cas9 To Complex Glycosylation In Bicsmentioning
confidence: 99%
“…The generic CRISPR-Cas9 vectors with DmU6 or BmU6-2 promoters did not allow CRISPR-Cas9 gene editing in Sf9 cells. However, the ability to manufacture indels was confirmed by sequencing using the CRISPR-Cas9 vector that has a SfU6-3 promoter (rather than DmU6 or BmU6-2) [ 127 ].…”
Section: The Future Of Crispr/cas9 To Complex Glycosylation In Bicsmentioning
confidence: 99%